Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Visningar
• 06/15/23
0
0
Bädda in
administrator
Prenumeranter
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna